Medical News

RSS

Lakeview Health System selects Lawson Software's multiple enterprise software solutions

Lawson Software today announced that Lakeview Health System has selected multiple enterprise software solutions, including Lawson Enterprise Financial Management, Supply Chain Management, Contract Management, and Budgeting and Planning suites. It also selected Lawson Time & Attendance and Scheduling modules as well as Lawson Business Intelligence.

2 Aug 2010

NYU PRC receives $3.2M award to establish Comparative Effectiveness Research Program

The NYU Health Promotion and Prevention Research Center at the NYU School of Medicine announced it has received a $3.2 million award from the Centers for Disease Control and Prevention to establish a Comparative Effectiveness Research Program focused on hypertension and colorectal cancer health disparities in African-American men in New York City.

2 Aug 2010

ARO uses Elekta VMAT system for prostate cancer patients

In the expansive region of Australasia—which includes Australia, New Zealand and neighboring islands—Auckland Radiation Oncology Centre is the first to use Elekta VMAT, treating a patient with prostate cancer using a single 100-second arc of radiation. Such rapid treatments change the entire therapy experience for these patients, who have had to remain completely still for seven minutes during radiation delivery for each of 37 to 39 separate treatment sessions or "fractions."

From Elekta 2 Aug 2010

RoundTable announces establishment of new platform business in ophthalmology market

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.

2 Aug 2010

Senate may vote today on extending extra Medicaid funds

"The Senate votes tonight on a cloture motion on a $26.1 billion domestic spending package that includes $10 billion in funding to avert teacher layoffs and $16.1 billion in Medicaid aid by extending Federal Medical Assistance Percentage reimbursements. That vote is a nod to House Democrats who are irked that senators stripped the funding from other bills and to governors who are lobbying for the funds" (Friedman, 8/2).

2 Aug 2010

OHSU acquires BSD-500 Hyperthermia System

BSD Medical Corporation is pleased to announce that Oregon Health & Science University has acquired a BSD-500 Hyperthermia System. OHSU is a leading university that provides world-class treatment for the most complex health care needs. OHSU has been ranked in U.S. News & World Report's annual rankings as one of America's Best Hospitals for 15 consecutive years and has been recognized in the medical specialties of cancer and endocrinology.

2 Aug 2010

The NoliWhite Group launches innovative process to integrate iPad on hospital construction sites

The NoliWhite Group, Brentwood-based healthcare facility developers, launched an innovative process that will incorporate the use of Apple's iPad on hospital and other healthcare-related construction sites, officials announced today. The initiative, Project Information Integration, or PI2, is being piloted on the construction of John D. Archbold Memorial Hospital's new North Tower in Thomasville, GA.

2 Aug 2010

Today's OpEds: Medicaid and the safety net; Health reform law's impact on long-term care and health costs

Late last week, the federal government provided a road map [for how to help those with little access to care] by extending an existing agreement that allows up to $25 million in Medicaid payments to hospitals to be diverted instead to clinics that serve the uninsured. You might think that would be a hard sell for hospitals; after all, they're experiencing sharp growth in the number of uninsured patients they serve. But St. Louis-area hospitals willingly have been sharing those payments with clinics for a decade. Without them, there simply wouldn't be a health care safety net to meet the region's needs (8/1).

2 Aug 2010

Taligen Therapeutics to highlight three pipeline candidates at XXIII ICW

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that preclinical data on three of its pipeline candidates will be highlighted at the XXIII International Complement Workshop taking place August 1-5, 2010, in New York City.

2 Aug 2010

Take Care Health Systems applauds US Senate for declaration of National Convenient Care Clinic Week

Take Care Health Systems, a wholly-owned subsidiary of Walgreens and the nation's largest and most comprehensive manager of convenient care clinics and worksite health and wellness centers, today praised the US Senate for its declaration of August 2-8 as "National Convenient Care Clinic Week". The resolution was introduced by Senator Daniel Inouye (D-HI) and Senator Thad Cochran (R-MS) and passed the Senate by unanimous consent.

2 Aug 2010

Research findings could lead to new drugs that reduce severity of blood infections leading to sepsis

Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.

2 Aug 2010

WellDoc DiabetesManager System receives FDA clearance

WellDoc, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, today announced that it has received United States Food and Drug Administration 510(k) clearance to market the WellDoc DiabetesManager System to healthcare providers and their adult patients with type 2 diabetes.

2 Aug 2010

BGU Professor awarded grant to develop target-specific, anti-cancer drugs

Ben-Gurion University of the Negev Professor Varda Shoshan-Barmatz has been awarded a three-year, $600,000 grant from the U.S. Leukemia & Lymphoma Society to develop target-specific, anti-cancer drugs.

2 Aug 2010

KHN column: Why the health reform repealers are wrong

"The effort to repeal health care reform, all in one fell swoop, seems to be stalling. Instead, the opponents of reform are trying to dismantle it piece by piece. The latest effort came last week, when a group of Republicans in the Senate proposed abolishing the Independent Payment Advisory Board. And therein lies a lesson about the future of American health care--and the two different shapes it could take" (8/2).

2 Aug 2010

Cardioxyl Pharmaceuticals achieves positive results in first clinical study of CXL-1020 for ADHF

Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.

2 Aug 2010

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

RegeneRx Biopharmaceuticals, Inc. today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4, is essential to healthy heart development and embryonic survival.

2 Aug 2010

StatRad introduces Stat360 teleradiology solution

StatRad, a leading provider of premier teleradiology services, announces today the introduction of Stat360, the most comprehensive teleradiology solution on the market. Stat360 combines traditional teleradiology services with PACS and live support from virtual radiology assistants with radiologist productivity in mind.

2 Aug 2010

U.S. gastroenterologists prescribe Abbott's Humira off-label for treating ulcerative colitis: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 63 percent of surveyed U.S. gastroenterologists prescribe Abbott's Humira off-label for the treatment of ulcerative colitis. According to the new report entitled Treatment Algorithms in Ulcerative Colitis, surveyed gastroenterologists most often prescribe Humira for ulcerative colitis for patients with loss of response, intolerance or no response to Centocor Ortho Biotech's Remicade.

2 Aug 2010

Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases

Repligen Corporation today announced that the Company has received three additional grants to support its research program to develop HDAC inhibitors for neurodegenerative diseases. Repligen has received $436,000 in research funding to support the ongoing development of histone deacetylase inhibitors for Friedreich's ataxia.

2 Aug 2010

Osteologix grants Servier Research Group exclusive license to develop, commercialize NB S101

Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.

2 Aug 2010

Medical News

Lakeview Health System selects Lawson Software's multiple enterprise software solutions

NYU PRC receives $3.2M award to establish Comparative Effectiveness Research Program

ARO uses Elekta VMAT system for prostate cancer patients

RoundTable announces establishment of new platform business in ophthalmology market

Senate may vote today on extending extra Medicaid funds

OHSU acquires BSD-500 Hyperthermia System

The NoliWhite Group launches innovative process to integrate iPad on hospital construction sites

Today's OpEds: Medicaid and the safety net; Health reform law's impact on long-term care and health costs

Taligen Therapeutics to highlight three pipeline candidates at XXIII ICW

Take Care Health Systems applauds US Senate for declaration of National Convenient Care Clinic Week

Research findings could lead to new drugs that reduce severity of blood infections leading to sepsis

WellDoc DiabetesManager System receives FDA clearance

BGU Professor awarded grant to develop target-specific, anti-cancer drugs

KHN column: Why the health reform repealers are wrong

Cardioxyl Pharmaceuticals achieves positive results in first clinical study of CXL-1020 for ADHF

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

StatRad introduces Stat360 teleradiology solution

U.S. gastroenterologists prescribe Abbott's Humira off-label for treating ulcerative colitis: Report

Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases

Osteologix grants Servier Research Group exclusive license to develop, commercialize NB S101

Squid™ Full Range Pipette: Reduce pipette changes, bench clutter, and calibration burden

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

Latest News